Authors:
MULLEN GM
SILVER MA
LAWLESS CE
MENDEZ J
BARATH PC
MALINOWSKA K
PISANI BA
OKEEFE PJ
ROBINSON JA
YELDANDI V
Citation: Gm. Mullen et al., ORAL GANCICLOVIR PROPHYLAXIS REDUCES CYTOMEGALOVIRUS DISEASE DURING THE FIRST YEAR AFTER HEART-TRANSPLANTATION, Journal of the American College of Cardiology, 31(2), 1998, pp. 157-157
Authors:
WALSH TJ
YELDANDI V
MCEVOY M
GONZALEZ C
CHANOCK S
FREIFELD A
SEIBEL NI
WHITCOMB PO
JAROSINSKI P
BOSWELL G
BEKERSKY I
ALAK A
BUELL D
BARRET J
WILSON W
Citation: Tj. Walsh et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2391-2398
Authors:
SOLANS E
YELDANDI V
GARRITY E
GATTUSO P
HUSAIN A
Citation: E. Solans et al., PATTERNS OF ASPERGILLUS INFECTION IN LUNG-TRANSPLANT PATIENTS, Laboratory investigation, 70(1), 1994, pp. 10000155-10000155